BrightGene Bio-Medical Technology Co. Ltd.SSE: 688166

Announcement on Shareholding Reduction Plan for Shareholders

Jun 13, 2026 · Issued by BrightGene Bio-Medical Technology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 13, 2026

On 6ix: 6ix.com/news/announcement-on-shareholding-reduction-plan-for-shareholders-151

Announcement on Shareholding Reduction Plan for Shareholders

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

BrightGene Bio-Medical Technology Co. Ltd. on 6ix

Earlier from BrightGene Bio-Medical Technology

Announcement on Voluntary Disclosure on the Acceptance of New Drug Application for BGM0504 Injection for Weight Loss IndicationJun 12
Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit DistributionJun 3
Announcement on Resignation of Directors and Secretary of the Board of DirectorsMay 27
Announcement on Redemption Results of "BrightGene Convertible Bonds" and Share ChangesMay 23
The Last Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"May 21

Later from BrightGene Bio-Medical Technology

Announcement on Actual Controller Being Released on Bail Pending TrialJun 19
Announcement on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change RegistrationJun 25
Announcement on Serious Abnormal Fluctuations in Stock TradingJul 1
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jul 11
Announcement on Abnormal Fluctuations in Stock TradingJul 17

All BrightGene Bio-Medical Technology news releases

Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.

Follow BrightGene Bio-Medical Technology